高宏集团 COWN 深 沪
已收盘 03-01 16:00:00 美东时间
38.99
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 38.99
- 总市值 11.01亿
- 52周最高 38.95
- 市盈率 静 17.65
- 换手率 0.00%
- 52周最低 20.97
- 委 比 0.00%
- 总股本 2824.23万
- 历史最高 43.27
- 量 比 0
- 振 幅 0.00%
- 历史最低 4.61
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LENZ plunges after adverse event report on eye therapy
Shares of LENZ Therapeutics (LENZ) fell ~26% on Friday, a move TD Cowen attributed to investor worries over an adverse event reported on a federal database about the company’s newly launched eye thera...
12-13 03:03
Adobe Q4: 'Sticky' Products, Soaring AI Use
JPMorgan analysts weighed in on Adobe's Q4, highlighting the "stickiness" of its product ecosystem.
12-12 07:45
TD Cowen Maintains Buy on Royalty Pharma, Raises Price Target to $45
TD Cowen analyst Steve Scala maintains Royalty Pharma (NASDAQ:RPRX) with a Buy and raises the price target from $42 to $45.
12-12 00:29
What analysts are saying about Coca-Cola's CEO hire
Analysts weighed in on Thursday on Coca-Cola Company (KO) announcing that its board of directors has set a succession plan for the beverage giant, with Chief Operating Officer Henrique Braun selected ...
12-11 22:34
Darling Ingredients, Tessenderlo Group to combine collagen and gelatin units
Darling Ingredients (DAR) (NYSE:DAR) on Wednesday said it has signed a definitive agreement with Tessenderlo Group (XBRU: TESB) to combine the collagen and gelatin segments of their companies into a n...
12-11 05:45
Parsons Wins $88 Million Military Contract As US Fortifies Europe Air Bases
Parsons Corporation (PSN) stock rose after landing a significant air defense contract and TD Cowen's Gautam Khanna upgraded it to Buy.
12-10 21:29
Terns Announces Pricing of Upsized $650 Million Public Offering
Terns Pharmaceuticals announced the pricing of its upsized underwritten public offering of 16,250,000 shares of common stock at $40.00 per share, raising $650 million in gross proceeds. The company granted underwriters a 30-day option to purchase up to an additional 2,437,500 shares. Proceeds will be used for research, clinical trials, and development of key product candidates, including TERN-701. Jefferies, TD Cowen, and Leerink Partners are lea...
12-10 04:30
Market Whales and Their Recent Bets on SBUX Options
Investors with a lot of money to spend have taken a bearish stance on Starbucks...
12-10 03:02
CVS Health rises as analysts welcome long-term guidance (update)
Shares of CVS Health (CVS) added ~3% on Tuesday as Wall Street cheered the company’s long-term outlook, which, however, indicated an underwhelming revenue guidance for the managed care firm in 2026. B...
12-10 02:52
Terns Pharma Plans $400M Stock Offering To Fund Cancer Drug Development
Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage oncology company, today announced that it has commenced a proposed underwritten public offering of $400 million of shares of its
12-09 19:20
